Programa de detección de fallas de calidad en los medicamentos comercializados

dc.date.accessioned	2015
dc.date.available	2015
dc.date.issued	1999	es_ES
dc.identifier.citation	(1999) Programa de detección de fallas de calidad en los medicamentos comercializados. Rev Panam Salud Publica;6(3) -,sept. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=iso	es_ES
dc.identifier.uri	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=iso	es_ES
dc.identifier.uri	https://iris.paho.org/handle/10665.2/8897
dc.format.extent	ilus	es_ES
dc.format.extent	tab	es_ES
dc.relation.ispartofseries	Rev Panam Salud Publica;6(3),sept. 1999	es_ES
dc.subject	Qualidade dos Medicamentos Homeopáticos	pt_BR
dc.subject	Determinação	pt_BR
dc.subject	Vigilância de Produtos Comercializados	es_ES
dc.title	Programa de detección de fallas de calidad en los medicamentos comercializados	es_ES
dc.title.alternative	A program to detect defective drugs in the postmarketing period	en_US
dc.type	Journal articles	en_US
dc.rights.holder	Pan American Health Organization	en_US
dc.description.notes	Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance system	en_US